Cost analysis of GenoType® MTBDRplus and GenoType® MTBDRsl at the State Laboratory of São Paulo, Brazil

ABSTRACT Background: We aimed to evaluate the costs of GenoType® MTBDRplus and MTBDRsl incurred during the diagnosis of first- and second-line drug-resistant tuberculosis (TB) in São Paulo, Brazil. Methods: Mean and activity-based costs of GenoType® were calculated in a referral laboratory for TB in Brazil. Results: The mean cost value and activity-based cost of GenoType® MTBDRplus were USD 19.78 and USD 35.80 and those of MTBDRsl were USD 54.25 and USD 41.85, respectively. Conclusions: The cost of GenoType® MTBDRplus was reduced owing to the high number of examinations performed and work optimization.

摘要：背景：本研究旨在评估在巴西圣保罗，使用GenoType® MTBDRplus和MTBDRsl对一、二线抗药性结核病（TB）进行诊断过程中产生的成本。方法：在巴西一家结核病专科实验室中计算了GenoType®的平均成本和基于活动的成本。结果：GenoType® MTBDRplus的平均成本和基于活动的成本分别为19.78美元和35.80美元，而MTBDRsl分别为54.25美元和41.85美元。结论：由于检查数量众多和工作流程优化，GenoType® MTBDRplus的成本有所降低。